Relationship between therapeutic alliance, symptoms remission and function improvement in chronic nonspecific low back pain patients after a lumbar stabilization program
Not Applicable
- Conditions
- Chronic Nonspecific Low Back PainMusculoskeletal - Other muscular and skeletal disordersPhysical Medicine / Rehabilitation - Physiotherapy
- Registration Number
- ACTRN12610000829011
- Lead Sponsor
- Paulo Roberto Carvalho do Nascimento
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
back pain for more 6 six month with pain complaint when upon entry of the study
Exclusion Criteria
structural alteration at low limb and/or spine; surgery in abdominal or spine region; presence of red flags, clear signs of radiculopathy with alteration of reflex, dermatome and/or myotome (at least two of these signs must be positive in a same segment of spine); rheumathic disease in lumbar spine; urinary incontinence; cognitive impairment; obesity, pregnancy or puerperal period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic Alliance evaluated using the Work Alliance Inventory[At the middle of treatment after 4 weeks and in the end after 8 weeks];Muscle activation of the transversus abdominal, internal and external obliques abdominal evaluated with rehabilitative ultrasound imaging and superficial electromyography assessment of the internal oblique abdominal (inferior fibers) and multifidus. The assessment will be made in right and left sides.[Baseline before begin of treatment, at middle of treatment after 4 weeks and in the end after 8 weeks.];Function evaluated with Rolland Morris Questionaire[Baseline before begin of treatment, at middle of treatment after 4 weeks and in the end after 8 weeks.]
- Secondary Outcome Measures
Name Time Method Pain assessed using the McGill Questionnaire of Pain[Baseline before begin of treatment, at middle of treatment after 4 weeks and in the end after 8 weeks.];kinesiophobia measured with Tampa Scale for Kinesiophobia[just in baseline];Health Locus of Control using Multidimensional Health Locus<br>of Control Scale[just in baseline]